Keep saving lives by prescribing methadone and buprenorphine. Learn how initiations of each have changed in the era of high-potency synthetic opioids (HPSOs) like fentanyl and how to continue to provide person-centered care to people with opioid use disorder. We’re joined by Dr Melissa Weimer, @DrMelissaWeimer (Yale University). This episode is in honor of National Addiction Treatment Week (treataddictionsavelives.org).

Claim CME for this episode at curbsiders.vcuhealth.org!
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.

Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | Free CME!

Credits

Producers: Shawn Cohen MD, Kenneth Morford MD
Writer: Carolyn Chan MD MHS
Show Notes: Shawn Cohen MD
Infographic and Cover Art: Kenneth Morford MD
Hosts: Carolyn Chan MD. MHS Shawn Cohen MD, Natalie Stahl MD, Kenneth Morford MD
Reviewer: Kento Sonoda MD
Showrunner: Carolyn Chan, MD, MHS
Technical Production: PodPaste
Guest: Melissa Weimer DO MCR

Show Segments

Intro, disclaimer, guest bio 00:00
Guest one-liner 05:02
National Addiction Treatment Week 06:00
Case from Kashlak; Definitions 08:30
Starting methadone 11:01
Common methadone pitfalls 15:00
Buprenorphine precipitated opioid withdrawal 23:50
High-dose buprenorphine 32:20
Treating buprenorphine precipitated withdrawal 36:50
Low-dose buprenorphine 41:50
Maintenance dose of buprenorphine 48:15
ER buprenorphine 49:00
Take home points 53:31

#24 Treating OUD in the Fentanyl Era: ASAM Treatment Week with Dr. Melissa Weimer

The Curbsiders Internal Medicine Podcast

Transition, Barriers, and Access Issues

The AI-powered Podcast Player